These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 2587127)
41. Biotinidase deficiency: a treatable genetic disorder in the Saudi population. Joshi S; al-Essa MA; Archibald A; Ozand PT East Mediterr Health J; 1999 Nov; 5(6):1213-7. PubMed ID: 11924114 [TBL] [Abstract][Full Text] [Related]
42. Differential effects of biotin deficiency and replenishment on rat liver pyruvate and propionyl-CoA carboxylases and on their mRNAs. Rodríguez-Meléndez R; Pérez-Andrade ME; Díaz A; Deolarte A; Camacho-Arroyo I; Cicerón I; Ibarra I; Velázquez A Mol Genet Metab; 1999 Jan; 66(1):16-23. PubMed ID: 9973543 [TBL] [Abstract][Full Text] [Related]
43. Recovery from neurological deficits following biotin treatment in a biotinidase Km variant. Ramaekers VT; Brab M; Rau G; Heimann G Neuropediatrics; 1993 Apr; 24(2):98-102. PubMed ID: 8352834 [TBL] [Abstract][Full Text] [Related]
44. Biotinidase deficiency: the enzymatic defect in late-onset multiple carboxylase deficiency. Wolf B; Grier RE; Allen RJ; Goodman SI; Kien CL Clin Chim Acta; 1983 Jul; 131(3):273-81. PubMed ID: 6883721 [TBL] [Abstract][Full Text] [Related]
45. Neurologic symptoms of biotinidase deficiency: possible explanation. Suchy SF; McVoy JS; Wolf B Neurology; 1985 Oct; 35(10):1510-1. PubMed ID: 4033935 [TBL] [Abstract][Full Text] [Related]
46. The clinical spectrum of biotin-treatable encephalopathies in Saudi Arabia. Dabbagh O; Brismar J; Gascon GG; Ozand PT Brain Dev; 1994 Nov; 16 Suppl():72-80. PubMed ID: 7726384 [TBL] [Abstract][Full Text] [Related]
55. Biotinidase deficiency--a treatable entity. Gulati S; Passi GR; Kumar A; Kabra M; Kalra V; Verma IC Indian J Pediatr; 2000 Jun; 67(6):464-6. PubMed ID: 10932969 [TBL] [Abstract][Full Text] [Related]
56. Partial Biotinidase Deficiency Revealed Imbalances in Acylcarnitines Profile at Tandem Mass Spectrometry Newborn Screening. Cicalini I; Pieragostino D; Rizzo C; Verrocchio S; Semeraro D; Zucchelli M; Di Michele S; Dionisi-Vici C; Stuppia L; De Laurenzi V; Bucci I; Rossi C Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33572391 [TBL] [Abstract][Full Text] [Related]
57. A biotinidase Km variant causing late onset bilateral optic neuropathy. Ramaekers VT; Suormala TM; Brab M; Duran R; Heimann G; Baumgartner ER Arch Dis Child; 1992 Jan; 67(1):115-9. PubMed ID: 1739323 [TBL] [Abstract][Full Text] [Related]
58. Biotinidase deficiency: early neurological presentation. Collins JE; Nicholson NS; Dalton N; Leonard JV Dev Med Child Neurol; 1994 Mar; 36(3):268-70. PubMed ID: 8138076 [TBL] [Abstract][Full Text] [Related]
59. Biotinidase deficiency: result of treatment with biotin from age 12 years. Casado de Frías E; Campos-Castelló J; Careaga Maldonado J; Pérez Cerdá C Eur J Paediatr Neurol; 1997; 1(5-6):173-6. PubMed ID: 10728214 [TBL] [Abstract][Full Text] [Related]
60. Biotin-dependent carboxylase activities in different CNS and skin-derived cells, and their sensitivity to biotin-depletion. Suormala T; Wiesmann UN; Cruz F; Wolf A; Daschner M; Limat A; Fowler B; Baumgartner ER Int J Vitam Nutr Res; 2002 Jul; 72(4):278-86. PubMed ID: 12214565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]